CCM

Cutter Capital Management Portfolio holdings

AUM $230M
1-Year Est. Return 11.51%
This Quarter Est. Return
1 Year Est. Return
+11.51%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$244M
AUM Growth
-$94.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
38
New
Increased
Reduced
Closed

Top Buys

1
+$20.5M
2
+$18.1M
3
+$12.9M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$12.1M
5
AMGN icon
Amgen
AMGN
+$9.93M

Top Sells

1
+$30.1M
2
+$29.7M
3
+$17.9M
4
LEGN icon
Legend Biotech
LEGN
+$15.9M
5
LLY icon
Eli Lilly
LLY
+$15.3M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
REGN icon
1
Regeneron Pharmaceuticals
REGN
$81.9B
$22.4M 9.19%
31,500
+17,024
JNJ icon
2
Johnson & Johnson
JNJ
$499B
$20.5M 8.39%
+141,572
RPRX icon
3
Royalty Pharma
RPRX
$16.6B
$19.5M 8%
764,859
+100,000
ABBV icon
4
AbbVie
ABBV
$403B
$18.1M 7.43%
+101,996
RARE icon
5
Ultragenyx Pharmaceutical
RARE
$3.35B
$17.1M 7.01%
406,803
+120,000
BBIO icon
6
BridgeBio Pharma
BBIO
$14.9B
$15.4M 6.3%
560,344
+163,956
SRPT icon
7
Sarepta Therapeutics
SRPT
$2.22B
$15.1M 6.19%
124,256
+40,500
INSM icon
8
Insmed
INSM
$37.5B
$14.6M 5.97%
210,884
-5,000
TEVA icon
9
Teva Pharmaceuticals
TEVA
$35.8B
$12.9M 5.28%
+584,883
VRDN icon
10
Viridian Therapeutics
VRDN
$3.1B
$12.1M 4.94%
628,677
+110,000
AMGN icon
11
Amgen
AMGN
$178B
$9.93M 4.07%
+38,090
AGIO icon
12
Agios Pharmaceuticals
AGIO
$1.45B
$9.91M 4.06%
301,623
+115,000
VERA icon
13
Vera Therapeutics
VERA
$3.82B
$8.99M 3.69%
212,696
+39,820
NAMS icon
14
NewAmsterdam Pharma
NAMS
$4.14B
$8.66M 3.55%
+337,152
MRNA icon
15
Moderna
MRNA
$13.6B
$8.21M 3.37%
+197,500
PRGO icon
16
Perrigo
PRGO
$1.85B
$7.57M 3.1%
294,517
-263,420
JANX icon
17
Janux Therapeutics
JANX
$847M
$6.42M 2.63%
+120,000
AKRO
18
DELISTED
Akero Therapeutics
AKRO
$6.4M 2.62%
+230,000
TARS icon
19
Tarsus Pharmaceuticals
TARS
$3.48B
$6.23M 2.55%
+112,500
CNTA
20
Centessa Pharmaceuticals
CNTA
$3.75B
$2.46M 1.01%
+147,076
NMRA icon
21
Neumora Therapeutics
NMRA
$308M
$1.59M 0.65%
+150,000
ELVN icon
22
Enliven Therapeutics
ELVN
$1.06B
– –
-207,896
GILD icon
23
Gilead Sciences
GILD
$154B
– –
-359,025
HRMY icon
24
Harmony Biosciences
HRMY
$2.24B
– –
-376,315
A icon
25
Agilent Technologies
A
$39.2B
– –
-120,485
1
2